Dr. Goez is primarily focused on research involving Filovirus induced disease which is highly lethal to humans and for which there are no FDA approved vaccines or therapies. Currently, she participates in animal studies that support well characterize models of human disease. Animal studies involving filoviruses are conducted in the maximum containment biosafety level 4 (BSL-4) laboratory which permits safe study of those pathogens.
- Ebola virus, Marburg virus
- Advanced development of vaccines for hemorrhagic fever viruses
- New detection methods for bioterror agents
Dr. Goez graduated from the University of Antioquia in Medellin, Colombia and has since been active in scientific research.
Inside the Lab
Dr. Goez is involved in preparing study protocols for natural history or efficacy studies in close collaboration with Government and Private Sponsors. As a study director, Dr. Goez has overall responsibility for the technical conduct of the study (following good laboratory practice regulations), as well as for the interpretation, analysis, documentation, and reporting of results. Along with other members of Dr. Carrion’s team, Dr. Goez worked to characterize an NHP model of filovirus infection via the pulmonary route. Dr. Goez also supports pathology efforts in the ABSL-4 performing necropsy of animals enrolled in BSL4 studies.
Main Technologies and Methods Used
- BSL-4 laboratory research
- Filovirus macaque models
- Ebolavirus small animal model development